Molecular detection and characterization of drug-resistant Mycobacterium tuberculosis by Engström, Anna
 Institutionen för mikrobiologi, tumör- och cellbiologi 
Molecular Detection and 
Characterization of Drug-Resistant 
Mycobacterium tuberculosis 
AKADEMISK AVHANDLING 
som för avläggande av teknologie doktorsexamen vid Karolinska 
Institutet offentligen försvaras i Gard-aulan, Smittskyddsinstitutet, 
Nobels väg 18 
Fredagen den 17 maj, 2013, kl 09.00 
av 
Anna Engström 
Civilingenjör i molekylär bioteknik 
Huvudhandledare:  
Doktor Pontus Juréen 
Karolinska Institutet, Institutionen för  
mikrobiologi, tumör- och cellbiologi, 
och Smittskyddsinstitutet 
 
Bihandledare:  
Docent Sven Hoffner 
Karolinska Institutet, Institutionen för  
mikrobiologi, tumör- och cellbiologi, 
och Smittskyddsinstitutet 
 
Professor Mats Nilsson 
Stockholms universitet, 
Institutionen för biokemi och biofysik 
 
Doktor Margareta Krabbe 
Uppsala universitet, Institutionen för  
biologisk grundutbildning 
 
Professor Diarmaid Hughes 
Uppsala universitet, Institutionen för  
medicinsk biokemi och mikrobiologi 
 
Fakultetsopponent: 
Doktor Hanna Soini 
Mycobacterial Reference Laboratory, 
National Institute for Health and Welfare, 
Turku, Finland 
 
Betygsnämnd: 
Docent Afshin Ahmadian 
Kungliga Tekniska högskolan, 
Skolan för bioteknologi 
 
Professor Sven Britton 
Karolinska Institutet,  
Institutionen för medicin 
 
Docent Barbro Olsson Liljequist 
Karolinska Institutet, Institutionen för 
mikrobiologi, tumör- och cellbiologi, 
och Smittskyddsinstitutet 
 
Stockholm 2013 
ABSTRACT 
 
Tuberculosis (TB) is an ancient disease, but not a disease of the past. Despite the declaration of TB as a 
global emergency by the World Health Organization in 1993 the worldwide problem of TB has worsened. 
The increasing prevalence of drug-resistant strains of Mycobacterium tuberculosis, the causative agent of 
TB, demands new measures to combat the situation. Rapid and accurate diagnosis of the pathogen, and its 
drug susceptibility pattern, is essential for timely initiation of treatment, and ultimately, control of the 
disease. Furthermore, knowledge about which precise mutations confer drug resistance in M. tuberculosis 
does not only lead to a basic understanding of drug resistance mechanisms and drug actions, but is also 
important for the design and development of clinically sensitive and specific molecular methods aiming at 
detecting drug-resistant M. tuberculosis.  
 
Paper I in this thesis investigated cross-resistance between the aminoglycosides amikacin (AMK) and 
kanamycin (KAN), and the cyclic peptide capreomycin (CAP). The results show that tlyA is neither a 
sensitive nor a specific genetic marker for detection of CAP resistance in M. tuberculosis, and that it is 
advisable to include rrs nucleotide position 1401 in a molecular-based assay for the detection of AMK-, 
KAN- and CAP-resistant M. tuberculosis clinical isolates. Paper II aimed at developing a pyrosequencing 
method for detection of first- and second-line resistance in M. tuberculosis. Pyrosequencing assays were 
developed for the genes rpoB, katG, embB, rrs, gyrA and the promoter regions of inhA and eis, which are 
associated with resistance to rifampicin (RIF), isoniazid, ethambutol, AMK, KAN, CAP and 
fluoroquinolones, respectively. Pyrosequencing is a highly throughput and robust method for detection of 
novel and a priori known mutations. The method can be used to screen a large sample volume, which is 
desired if aiming at investigating the prevalence of mutations in large sample collections. In Paper III, the 
utility of padlock probes for detecting drug resistance in M. tuberculosis was evaluated. The assay was 
developed for RIF resistance due to the importance of RIF in the standard TB treatment and its potential role 
as a surrogate marker for multidrug-resistant TB. The method proved to be robust for detection of specific 
mutations in the gene rpoB, and confirmation of loss of wild type as well as detection of M. tuberculosis 
complex DNA. The padlock probe assay was further extended in Paper IV to detection of extensively drug-
resistant TB in a multiplexed fashion. Padlock probes were designed to target the most common mutations 
occurring in rpoB, katG, rrs, gyrA and in the promoter region of inhA. The analytical sensitivity achieved in 
Paper IV is comparable to that of PCR. The readout format employed in Paper IV eliminates the use of 
extensive equipment, but rather, signal can be detected by the naked eye. 
 
This thesis has contributed to increased knowledge of drug resistance in TB, and has successfully developed 
new methods for rapid detection of drug-resistant M. tuberculosis. The results can guide future research and 
development of molecular methods aiming at detecting drug-resistant M. tuberculosis. 
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